Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement
- PMID: 17659829
- DOI: 10.1016/j.eururo.2007.07.027
Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement
Abstract
Objectives: To evaluate the feasibility and safety of nerve-sparing radical retropubic prostatectomy (NSRRP) for localised prostate cancer after holmium laser enucleation of the prostate (HoLEP) for bladder outlet obstruction due to benign prostatic enlargement (BPE).
Methods: Fifteen consecutive patients with prostate cancer following HoLEP underwent NSRRP. They were matched with an equal number of patients who also underwent NSRRP following transurethral resection of the prostate (TURP group) or open prostatectomy (OP group). Patients were preoperatively assessed with validated questionnaires (International Prostate Symptom Score [IPSS] and International Index of Erectile Function-Erectile Function [IIEF-EF]). Intraoperative, perioperative, and follow-up functional data according to validated questionnaires (IPSS, IIEF-EF, International Consultation on Incontinence Questionnaire-Short Form [ICIQ-SF]) were evaluated with analysis of variance and chi2 tests.
Results: At diagnosis, the prostate-specific antigen (PSA) level, clinical stage, Gleason sum distributions, body mass index, ICIQ-SF, and IPSS were not significantly different among the groups. IIEF-EF scores was higher in the HoLEP group (p=0.02). Mean operative time was longer in the OP group (p=0.02), but no difference was found in mean blood loss (p=0.5). Final pathology showed no substantial differences among the groups, although a lower positive surgical margin rate was found in the HoLEP group (p=0.04). Mean follow-up was 23.8+/-10.5 mo. The groups showed no statistical differences in urinary continence rate (p=0.6), IPSS (p=0.3), or IIEF-EF (p=0.4).
Conclusions: NSRRP is feasible in prostate cancer patients who previously underwent HoLEP for BPE and provides satisfactory functional outcomes.
Comment in
-
Prostate cancer following BPH treatments: what the patient should know.Eur Urol. 2008 Jun;53(6):1109-10. doi: 10.1016/j.eururo.2007.07.036. Epub 2007 Aug 3. Eur Urol. 2008. PMID: 17681420 No abstract available.
Similar articles
-
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15. BJU Int. 2012. PMID: 22702908
-
Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up.Eur Urol. 2006 Sep;50(3):563-8. doi: 10.1016/j.eururo.2006.04.003. Epub 2006 May 2. Eur Urol. 2006. PMID: 16713070 Clinical Trial.
-
Holmium laser enucleation of the prostate: results at 6 years.Eur Urol. 2008 Apr;53(4):744-9. doi: 10.1016/j.eururo.2007.04.052. Epub 2007 Apr 23. Eur Urol. 2008. PMID: 17475395
-
Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature.BJU Int. 2007 Jul;100(1):94-101. doi: 10.1111/j.1464-410X.2007.06867.x. Epub 2007 Apr 5. BJU Int. 2007. PMID: 17419697 Review.
-
Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome.Curr Opin Urol. 2009 Jan;19(1):38-43. doi: 10.1097/MOU.0b013e32831a7008. Curr Opin Urol. 2009. PMID: 19057214 Review.
Cited by
-
Discrepancies in perception of urinary incontinence between patient and physician after robotic radical prostatectomy.Yonsei Med J. 2010 Nov;51(6):883-7. doi: 10.3349/ymj.2010.51.6.883. Yonsei Med J. 2010. PMID: 20879055 Free PMC article.
-
Holmium Laser Enucleation of the Prostate: Patient Selection and Outcomes.Curr Urol Rep. 2017 Oct 19;18(12):96. doi: 10.1007/s11934-017-0746-z. Curr Urol Rep. 2017. PMID: 29046983 Review.
-
Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?Int Neurourol J. 2016 Sep;20(3):209-213. doi: 10.5213/inj.1632534.267. Epub 2016 Sep 23. Int Neurourol J. 2016. PMID: 27706011 Free PMC article.
-
Current Trends in Incidence and Management of T1a and T1b Prostate Cancer.Cureus. 2023 Jun 10;15(6):e40224. doi: 10.7759/cureus.40224. eCollection 2023 Jun. Cureus. 2023. PMID: 37435253 Free PMC article. Review.
-
How to Prevent and Manage Post-Prostatectomy Incontinence: A Review.World J Mens Health. 2021 Oct;39(4):581-597. doi: 10.5534/wjmh.200114. Epub 2020 Sep 10. World J Mens Health. 2021. PMID: 33151045 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous